In the pre-shock phase of septic shock in man may be suspected on the basis that this phase of shock, or "pre-shock" In man, is characterized by an increase in skin temperature, tachycardia, and elevated temperature; and when a small sublethal injection of endotoxin is given, rendi hyperemla is observed in patients. Therefore, it would be reasonable that following the injection of live E. co& organisms, there would be a period comparable to the "preshock" phase in man. The final point which must be evaluated is that the use of the live E. cotZ shock model may produce a more efficient and relevant clinical shock model in that the delayed period following the injection of organisms would be more comparable to that seen in man and would permit a more effective approach to therapy in the animal shock model. Future research will be required to elucidate similarities and differences between the models and provide the basis for a decision in regard to a more clinically relevant shock model for the study of septic shock in man. This document has been approved for public rel ase an6 sale; its distribution is .1
unlimited.
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I. ABSTRACT
There Is a growing concern regarding the failure to develop an effective treatment of septic stock in clinical medicine. Successful therapy would be immensely supported by an understanding of the basic mechanisms of the shock state. The development of a morE realistic animal model would greatly aid in elucidating clinical problems observed in the human patient. Preliminary research in this laboratory suggested some differences between endotoxin shock and shock produced by injection of live E. coli organisms in dogs. A primary purpose of our research has been to determine the effects of intravenous injections of living E. coli organisms in dogs and monkeys and compare them wit responses produced by endotoxin. Hemodynamc changes, pathologiL alterations, and metabolic abnormalities have been evaluated in animals receiving lethal and sublethal injections of live E. coli organisms and comparable dosages of purified endotoxin. Future research will be required to more thoroughly elucidate the similarities and differences between the models described in this report and provide the basis for a decision in regard to a more clinically relevant shock model for the study of sepTic shock In man.
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